FIBERCON

Dosage form: tablet
Ingredients: CALCIUM POLYCARBOPHIL 625mg
Labeler: Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.
NDC Code: 0005-2500

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Fibercon
(calcium polycarbophil)

Drug Facts

Active ingredient (in each caplet)Purpose
Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophilBulk-forming laxative

Uses

  • relieves occasional constipation to help restore and maintain regularity
  • this product generally produces bowel movement in 12 to 72 hours

Warnings

Choking:

Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

Ask a doctor before use if you have
  • abdominal pain, nausea, or vomiting
  • a sudden change in bowel habits that persists over a period of 2 weeks

Ask a doctor or pharmacist before use if you are

taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

When using this product
  • do not use for more than 7 days unless directed by a doctor
  • do not take more than 8 caplets in a 24 hour period unless directed by a doctor

Stop use and ask a doctor if

rectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take each dose of this product with at least 8 ounces (a full glass) of water or other fluid. Taking this product without enough liquid may cause choking. See choking warning.
  • FiberCon works naturally so continued use for one to three days is normally required to provide full benefit. Dosage may vary according to diet, exercise, previous laxative use or severity of constipation.
agerecommended dosedaily maximum
adults and children 12 years of age and over2 caplets once a dayup to 4 times a day
children under 12 yearsconsult a physician 

Other information

  • each caplet contains: 140 mg calcium and 10 mg magnesium
  • protect contents from moisture
  • store at 20-25°C (68-77°F)

Inactive ingredients

caramel, crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, sodium lauryl sulfate

Questions or comments?

Call weekdays from 9 AM to 5 PM EST at 1-800-282-8805

PRINCIPAL DISPLAY PANEL - 36 Caplet Blister Pack Carton

FiberCon®

Calcium Polycarbophil Bulk-Forming Laxative

Fiber Therapy for Regularity


  • Gentle Enough for
    Everyday Use*
  • Won't Ferment to
    Cause Gas or Bloating
  • As Effective as
    Fiber Powders

*when used as directed

CONVENIENT
TRAVEL PACK!

36 Caplets

FIBERCON 
calcium polycarbophil tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0005-2500
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM POLYCARBOPHIL (POLYCARBOPHIL) CALCIUM POLYCARBOPHIL625 mg
Inactive Ingredients
Ingredient NameStrength
CARAMEL 
CELLULOSE, MICROCRYSTALLINE 
CROSPOVIDONE 
HYPROMELLOSES 
MAGNESIUM STEARATE 
POLYETHYLENE GLYCOLS 
SILICON DIOXIDE 
SODIUM LAURYL SULFATE 
Product Characteristics
ColorGRAY (Off white to grayish color depending on lighting) Scoreno score
ShapeOVALSize20mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:0005-2500-029 BLISTER PACK in 1 CARTON
14 TABLET in 1 BLISTER PACK
2NDC:0005-2500-331 BOTTLE in 1 CARTON
290 TABLET in 1 BOTTLE
3NDC:0005-2500-23140 TABLET in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33401/05/2004
Labeler - Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. (054065909)

Revised: 02/2013
 
Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)